The Optimal Time for Applying 5%Lidocaine Medicated Plaster to Decrease Protective Sensation of Skin

Main Article Content

Narut Ruananukun


Background: Eutectic mixture of local anesthetics is commonly used to reduce pain during cutaneous interventions but it must be applied under an occlusive bandage. It can cause vasoconstriction, methemoglobinemia and skin wrinkling. Five percent lidocaine medicated plaster (5%LMP), which is indicated for neuropathic pain, may be an alternative topical anesthetic. However, there is no data about its relationship between time and level of decreasing protective sensation of skin. Objective: To determine the optimal time for applying 5%LMP to decrease protective sensation of skin. Materials and Methods: Twenty healthy adult volunteers were tested for baseline sensation at dorsum of hand by the Semmes-Weinstein monofilaments kit, then they were tested hourly for 8 hours after applied 5%LMP. Sensory levels were recorded as A-level to T-level which G-level means diminish protective sensation. The main result was the onset time which defined as the time when G-level monofilament cannot be detected. The median time of the onset was analyzed. Results: The volunteers were 10 for each sex and their mean age was 30.65 + 5.9 years. All male volunteers were able to reach G-level, but females were 30% fail to reach the G-level within 8 hours. The median onset time was 5 hours (95%CI:2.809-7.191) but there was different between male and female (P=0.000); which were 3 hours (95%CI:1.482- 4.518) and 7 hours (95%CI:4.934-9.006) respectively. No skin wrinkling or any complications were observed. Conclusion: Applying 5%LMP to decrease protective sensation of skin takes at least 5 hours. This may take longer time in female

Article Details

Original articles


1. Lirk P, Berde CB. Local anesthetic. In: Gropper MA, editor.
Miller’s Anesthesia. 9th ed, Philadelphia: Elsevier; 2020.
2. Wilder-Smith E, Chow A. Water immersion and EMLA cause
similar digit skin wrinkling and vasoconstriction. Microvasc
Res 2003;66: 68-72.
3. Egekvist H, Bjerring P. Effect of EMLA cream on skin
thickness and subcutaneous venous diameter. a randomized,
placebo-controlled study in children. Acta Derm Venereol
2000;80: 340-3.
4. Shamriz O, Cohen-Glickman I, Reif S, Shteyer E. Methemoglobinemia induced by lidocaine-prilocaine cream. Isr Med
Assoc J 2014;16: 250-4.
5. Hans G, Sabatwoski R, Binder A, Boesl I, Rogers P, Baron
R. Efficacy and tolerability of a 5% lidocaine medicated
plaster for the topical treatment of post-herpetic neuralgia:
results of a long-term study. Curr Med Res Opin 2009;25:
6. Sabatowski R, Hans G, Tacken I, Kapanadze S, Buchheister B,
Baron R. Safety and efficacy outcomes of long-term treatment
up to 4 years with 5% lidocaine medicated plaster in patients
with post-herpetic neuralgia. Curr Med Res Opin 2012;28:
7. Derry S, Wiffen PJ, Moore RA, Quinlan J. Topical lidocaine
for neuropathic pain in adults. Cochrane Database Syst Rev.
2014(7); CD010958.
8. Bain LJ, Engelhardt M. Statistical analysis of reliability and
life-testing models. Theory and methods. 2nd ed. New York:
Marcel Dekker; 1991.
9. Lignopad®
medicated plaster 5% information [Internet]; 2014.
[cited 2021 May 22]. Available from:
10. Rehabilitation Division (Rolyan-Ability One, Germantown, WI,
USA). Rolyan*Monofilaments “Semmes-Weinstein” [Internet].
Nottinghamshire: England, Smith & Nephew Homecraft; 1998
[cited 2021 May 10]. 31 p. Available from: https://www.
11. Palmeira CC, Ashmawi HA, Posso Ide P. Sex a nd pain
perception and analgesia. Rev Bra Anestesiol 2011;61: